Fact CheckerSign in

NCT06521489Active, not recruiting

Asymmetrical HFNCO vs Standard HFNCO Post Cardiac Surgery Patients

Study of Asymmetrical High Flow Nasal Cannula Oxygenation (HFNCO) vs Standard HFNCO on Cardiac Surgical Patients Postoperatively

Source: ClinicalTrials.gov · Last updated 17 Mar 2026

Brief summary (registry, in English)

High-flow oxygen therapy has been applied after extubation in cardiac surgery patients with a well-known successful efficacy. The current authors plan to conduct a prospective, randomized, controlled study of the Asymmetrical device Nasal Cannula High Flow Oxygenation (HFNCO) application on high flow (60L/min) with 60% fiO2 administration versus Conventional device Nasal Cannula High Flow Oxygenation (HFNCO) application on high flow (60L/min) with 60% fiO2 administration and versus Conventional oxygen treatment (Venturi mask) after extubation of patients undergoing elective or non-elective cardiac surgery.

Status (registry)
Active, not recruiting
Study type
Interventional
Enrollment
63 (actual)
First submitted
11 Jul 2024
Start date
1 May 2024
Primary completion date
1 Sept 2026
Lead sponsor
National and Kapodistrian University of Athens
NCT number
NCT06521489

What you commit to

  • Study type: Interventional
  • Participants enrolled: 63
  • From 1 May 2024 to the primary completion date, 1 Sept 2026
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Other illness

  • Obstructive Sleep Apnea Syndrome supported by CPAP mask on ventilator
  • Visual or hearing impairment.

Lab values

  • COPD, officially diagnosed, respiratory failure - on exacerbation with serum blood pH \<7,35.

Other

  • Patients with tracheostomy,
  • DNR status,
  • Glasgow Coma Scale score \< 13,
  • Insufficient knowledge of the Greek Language

Who the study is looking for

  • Cardiac ICU adult patients
  • \>18 years
  • After elective or urgent cardiac surgery
  • Successful Spontaneous Breathing Trial (SBT) with T-piece and FiO2=60%.
  • pO2/ FiO2 \<150
  • Hemodynamically stable (160\>SAP\>90mmHg)

Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
Evangelismos General Hospital of Athens
Coordinator of this site? Confirm its status
AthensGreeceUnknown status

This page is information, not medical advice. Discuss any trial with your doctor.